Gilead Sciences
GILD
#129
Rank
C$209.96 B
Marketcap
C$169.22
Share price
-1.14%
Change (1 day)
32.16%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2025 (TTM): C$9.14

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C$9.10. In 2024 the company made an earnings per share (EPS) of C$0.53 a decrease over its 2023 EPS that were of C$6.35.

EPS history for Gilead Sciences from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$9.141622.75%
2024C$0.53-91.65%
2023C$6.3523.98%
2022C$5.12-25.86%
2021C$6.914850%
2020C$0.14-97.64%
2019C$5.920.9%
2018C$5.8718.71%
2017C$4.94-64.88%
2016C$14.07-18.45%
2015C$17.2555.28%
2014C$11.11296.02%
2013C$2.8117.89%
2012C$2.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
C$18.19 99.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$20.00 119.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$1.89-79.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$6.24-31.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$15.34 68.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$2.40-73.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
C$14.57 60.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$28.64 214.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$10.60 16.47%๐Ÿ‡บ๐Ÿ‡ธ USA